Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
10.93
-0.01 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
10.94
+0.01 (0.09%)
After-hours: Dec 5, 2025, 7:24 PM EST
Evoke Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 24 | 9 | 4 | 9 | 18 | 68 | |
| Market Cap Growth | 236.70% | 160.15% | -60.81% | -50.12% | -73.62% | 73.44% | |
| Enterprise Value | 17 | 3 | 3 | 2 | 12 | 64 | |
| Last Close Price | 10.93 | 4.42 | 12.60 | 32.16 | 79.20 | 371.52 | |
| PS Ratio | 2.11 | 0.89 | 0.68 | 3.57 | 11.10 | 2957.72 | |
| PB Ratio | 7.01 | 1.30 | -1.36 | 2.19 | 5.05 | -21.18 | |
| P/TBV Ratio | 7.01 | 1.30 | - | 2.19 | 5.05 | - | |
| EV/Sales Ratio | 1.19 | 0.27 | 0.49 | 0.70 | 7.34 | 2777.86 | |
| Debt / Equity Ratio | 1.52 | 0.73 | -1.94 | 1.26 | 1.41 | -1.63 | |
| Asset Turnover | 0.97 | 0.83 | 0.55 | 0.22 | 0.16 | 0.00 | |
| Inventory Turnover | 0.79 | 0.77 | 0.52 | 1.56 | 1.56 | - | |
| Quick Ratio | 1.21 | 1.54 | 0.56 | 6.33 | 6.72 | 1.07 | |
| Current Ratio | 1.27 | 1.66 | 0.71 | 7.09 | 7.51 | 1.23 | |
| Return on Equity (ROE) | -134.88% | -240.09% | -1035.44% | -215.30% | -5015.39% | -2256.53% | |
| Return on Assets (ROA) | -21.78% | -26.46% | -49.09% | -43.40% | -50.93% | -103.03% | |
| Return on Capital (ROIC) | -36.33% | -44.50% | -79.84% | -54.74% | -96.14% | -248.98% | |
| Return on Capital Employed (ROCE) | -152.30% | -72.90% | 288.10% | -76.40% | -88.90% | -687.30% | |
| Earnings Yield | -22.17% | -58.59% | -221.93% | -91.79% | -47.54% | -19.32% | |
| Buyback Yield / Dilution | -151.70% | -583.90% | -6.33% | -17.21% | -26.26% | -14.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.